HDAC2 and chronic obstructive pulmonary disease: In COPD patients treated with hormones, the expression of HDAC2 was upregulated, and NF-κB inhibited, leading to inhibition of the expression of IL-8 and other inflammatory factors, and finally, the patient's airway inflammation was alleviated.